These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1784002)

  • 21. Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: combined use of carboxymethyl-ethyl-beta-cyclodextrin and penetration enhancers.
    Uekama K; Adachi H; Irie T; Yano T; Saita M; Noda K
    J Pharm Pharmacol; 1992 Feb; 44(2):119-21. PubMed ID: 1352811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moisturizing lotions can increase transdermal absorption of the herbicide 2,4-dichlorophenoxacetic acid across hairless mouse skin.
    Brand RM; Charron AR; Sandler VL; Jendrzejewski JL
    Cutan Ocul Toxicol; 2007; 26(1):15-23. PubMed ID: 17464745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of transdermal delivery of prochlorperazine.
    Obata Y; Otake Y; Takayama K
    Biol Pharm Bull; 2010; 33(8):1454-7. PubMed ID: 20686248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of hydrocortisone permeation of human and hairless mouse skin by 1-dodecylazacycloheptan-2-one.
    Hou SY; Flynn GL
    J Invest Dermatol; 1989 Dec; 93(6):774-9. PubMed ID: 2584743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclodextrins as co-enhancers in dermal and transdermal drug delivery.
    Loftsson T; Másson M; Sigurdsson HH; Magnússon P; Le Goffic F
    Pharmazie; 1998 Feb; 53(2):137-9. PubMed ID: 9540112
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparative in vitro study of transdermal absorption of antiemetics.
    Calpena AC; Blanes C; Moreno J; Obach R; Domenech J
    J Pharm Sci; 1994 Jan; 83(1):29-33. PubMed ID: 8138905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azone analogues: classification, design, and transdermal penetration principles.
    Jampilek J; Brychtova K
    Med Res Rev; 2012 Sep; 32(5):907-47. PubMed ID: 22886628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of transdermal penetration enhancers using a novel skin alternative.
    Godwin DA; Michniak BB; Creek KE
    J Pharm Sci; 1997 Sep; 86(9):1001-5. PubMed ID: 9294812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the absorption enhancer, Azone, on the transport of 5-fluorouracil across hairless rat skin.
    Sugibayashi K; Hosoya K; Morimoto Y; Higuchi WI
    J Pharm Pharmacol; 1985 Aug; 37(8):578-80. PubMed ID: 2864423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of liver disease on pharmacokinetics and toxicity of 9-beta-D-arabinofuranosyladenine-5-phosphate.
    Preiksaitis JK; Lank B; Ng PK; Brox L; LePage GA; Tyrrell DL
    J Infect Dis; 1981 Oct; 144(4):358-64. PubMed ID: 6169773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of Azone of different concentrations on percutaneous absorption of baicalin in vitro].
    L ZP; Liu Q; Lu XW
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):1003-4. PubMed ID: 12433630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination effect of penetration enhancers and propylene glycol on in vitro transdermal absorption of insulin.
    Príborský J; Takayama K; Nagai T; Waitzová D; Elis J
    Drug Des Deliv; 1987 Dec; 2(2):91-7. PubMed ID: 3334547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of hairless rats as a model for predicting transdermal pharmacokinetics in humans.
    Yamamoto S; Sano N; Fukushi C; Arai Y; Karashima M; Hirabayashi H; Amano N
    Xenobiotica; 2020 Jul; 50(7):831-838. PubMed ID: 31814485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1.
    Williams BB; Bailey EJ; Lerner AM
    J Lab Clin Med; 1977 Apr; 89(4):687-91. PubMed ID: 191546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddI.
    Koudriakova T; Manouilov KK; Shanmuganathan K; Kotra LP; Boudinot FD; Cretton-Scott E; Sommadossi JP; Schinazi RF; Chu CK
    J Med Chem; 1996 Nov; 39(23):4676-81. PubMed ID: 8917656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride.
    Kato A; Ishibashi Y; Miyake Y
    J Pharm Pharmacol; 1987 May; 39(5):399-400. PubMed ID: 2886592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin.
    LePage GA; Worth LS; Kimball AP
    Cancer Res; 1976 Apr; 36(4):1481-5. PubMed ID: 946595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal drug delivery systems of albuterol: in vitro and in vivo studies.
    Gokhale R; Schmidt C; Alcorn L; Stolzenbach J; Schoenhard G; Farhadieh B; Needham T
    J Pharm Sci; 1992 Oct; 81(10):996-9. PubMed ID: 1432626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of penetration enhancers on the transdermal penetration of sinomenine liposome patch].
    Wang Y; Zhou L; Ling J
    Zhong Yao Cai; 2005 Jul; 28(7):567-70. PubMed ID: 16252723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Terbutaline transdermal delivery: preformulation studies and limitations of in-vitro predictive parameters.
    Tenjarla S; Puranajoti P; Kasina R; Mandal T
    J Pharm Pharmacol; 1996 Nov; 48(11):1138-42. PubMed ID: 8961161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.